By Investigative Staff
In the landscape of American healthcare, few sectors have seen as rapid and contentious a transformation as autism therapy. While federal headlines have focused on high-profile raids and allegations of immigrant welfare fraud, a deeper, more structural crisis has been unfolding in plain sight. An extensive investigation by The 74, leveraging a newly released dataset of 275 million Medicaid billing records, reveals a stark reality: the autism therapy industry has been aggressively co-opted by private equity firms, resulting in a $7 billion influx of taxpayer money that is increasingly detached from patient well-being and, in many cases, actively harmful to the children it claims to serve.
The crisis centers on Applied Behavior Analysis (ABA), a therapeutic model designed to modify behavior through rewards and punishments. While marketed as the "gold standard" for autism, ABA is facing a wave of scrutiny from researchers, disability advocates, and whistleblowers who argue the system has become a lucrative mechanism for profit-driven expansion at the expense of developmental health and educational rights.
The Rise of the For-Profit Behavioral Complex
For decades, autism therapy was a fringe, underfunded field. That changed in the mid-2000s, driven by grassroots parent advocacy—most notably the campaign for "Ryan’s Law" in South Carolina. Parents, desperate for interventions, successfully lobbied for insurance mandates that forced private insurers to cover ABA. When the Obama administration later clarified that the Affordable Care Act required Medicaid to cover these services, the floodgates opened.
Between 2019 and 2024, Medicaid claims for the six most common ABA billing codes surged by 381%, ballooning from $400 million to nearly $2 billion annually. This growth was not fueled by a surge in non-profit clinicians, but by the rapid entry of private equity (PE) firms. These firms, known for their "buy-and-build" strategies, acquired hundreds of independent clinics, consolidating them into massive, multi-state chains designed to maximize short-term cash flow before an eventual resale.
"Private equity was attracted to ABA because the industry had already set up a tidy financial arrangement for itself," says Ari Ne’Eman, a professor of health policy at Harvard’s T.H. Chan School of Public Health. "It’s not that private equity is corrupting a previously fine field. They entered the field because the flaws—lack of oversight, standardized high-intensity billing, and opaque credentialing—were already there."
A Chronology of Institutional Capture
The trajectory of the current crisis can be mapped through several distinct phases of expansion and exploitation:
- 1960s–1980s: The Lovaas Era. UCLA researcher Ole Ivar Lovaas develops ABA, utilizing a regime of behavioral conditioning. Later research would link Lovaas to the development of LGBTQ conversion therapy and reveal his involvement in the Norwegian Nazi youth movement.
- 2005–2007: The Advocacy Catalyst. Driven by the high costs of therapy, parents like Lorri Unumb launch a national movement to mandate insurance coverage for ABA, positioning it as the only viable "cure" for autism.
- 2014: The Medicaid Mandate. The federal government mandates that Medicaid cover autism services. The sudden availability of public funds creates a massive, reliable revenue stream.
- 2015–2018: The Private Equity Influx. Firms such as Blackstone and Martis Capital begin acquiring major autism service providers, including the Center for Autism and Related Disorders (CARD) and Centria Healthcare.
- 2022–2025: Federal Audits and "DOGE" Revelations. Federal audits across both red and blue states begin to flag widespread billing irregularities, including "cloned" treatment notes and the billing of custodial care as therapy. The U.S. Department of Government Efficiency (DOGE) releases massive datasets confirming the scale of the spending explosion.
Supporting Data: The Cost of "Efficiency"
The data provided by the DOGE dataset is sobering. Between 2019 and 2024, Medicaid paid out nearly $7 billion for ABA services—a sum that dwarfs the total federal investment in the Autism CARES Act over the last two decades. While the CARES Act funds life-improving services like job training and safety programs, the majority of public autism funding is currently locked into repetitive behavior modification.
Perhaps most damning is the evidence regarding the "intensity" of care. Industry standards often push for up to 40 hours of therapy per week for toddlers, a schedule that essentially serves as a full-time job for a three-year-old. Federal audits have repeatedly found that these centers are effectively supplanting the school system, keeping children in therapy clinics for years at a time, where they are denied their legal right to an education.
In one instance highlighted by auditors in Colorado, a child was kept in full-time ABA for 16 years, with Medicaid payments skyrocketing from $16,000 to $144,000 annually by the end of the period, all without an independent evaluation to determine if the treatment remained appropriate.
Official Responses and the "Bad Actor" Defense
The industry, represented by groups like the Council of Autism Service Providers, maintains that the system is functioning as intended. CEO Lorri Unumb, while acknowledging that "genuine fraud, waste, and abuse must be called out," argues that the sector is filled with ethical providers.
"Bad actors exist in every healthcare profession, including ABA, but that doesn’t mean they are prevalent," Unumb stated in an email to The 74.
Private equity firms, however, have remained largely silent or defensive. When faced with allegations of mismanagement, such as those leveled against CARD under Blackstone’s ownership, firms often point to the "perfect storm" of economic pressures, such as labor shortages and low reimbursement rates, to explain bankruptcies and facility closures. Blackstone, in its statement, claimed it never interfered with clinical decisions, despite former employees testifying that they were explicitly told to prioritize younger, high-hour patients over those with lower-intensity needs.
Implications: A Future in Jeopardy
The implications of this capture are profound. As the second Trump administration redirects federal resources and continues to withhold Medicaid funding from states it deems uncooperative, the most vulnerable in the autism community are being caught in the crossfire.
1. The Erosion of Educational Rights
By prioritizing clinical "compliance" over school-based learning, the ABA industry is creating a generation of students who have been effectively excluded from the inclusive education environments guaranteed by federal law. The transition to school for these children is often fraught with difficulty, as they have missed critical years of academic and social development.
2. The Trauma of Compliance
Independent research, including studies from the University of Wisconsin-Madison and the University of Texas, indicates a correlation between ABA and negative mental health outcomes. Individuals who underwent ABA before the age of 18 were found to be 30% more likely to experience mental health hospitalizations. Advocates argue that the focus on "extinguishing" autistic traits—such as hand-flapping or specific self-regulation methods—is inherently traumatic, mirroring the abusive history of conversion therapy.
3. The Regulatory Deadlock
Legislative attempts to curb these abuses, such as the recent law signed by Colorado Governor Jared Polis, have been criticized by the disability community as insufficient. Critics argue that these bills often grant licensing power to the very organizations that created the ABA industry, failing to bring in the necessary oversight from independent psychologists or the autistic adults who have lived through the system.
"This bill will have lasting consequences for autistics for decades," wrote Boulder parent Jenny Thamer in her testimony. Her warnings reflect a broader fear: that the state is not regulating the industry, but rather formalizing its control over the lives of autistic children.
As the financial machinery of private equity continues to extract billions from the public purse, the question remains whether the American healthcare system can pivot toward a model that values the autonomy and dignity of autistic individuals over the standardization of their behavior. For now, the "state of mind" described by observers as a market-driven, profit-first culture continues to dictate the terms of care for thousands of families, often with little regard for the long-term human cost.
